Secondary Logo

Current Issue Highlights

Focus on Pharmacodynamic Drug Monitoring

Absence of Relationship Between Crohn's Disease Activity Index or C-Reactive Protein and Infliximab Exposure Calls for Objective Crohn's Disease Activity Measures for the Evaluation of Treatment Effects at Treatment Failure

Edlund, Helena; Grisic, Ana-Marija; Steenholdt, Casper; More

Therapeutic Drug Monitoring. 41(2):235-242, April 2019.